Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer
{{output}}
Objectives: Small-cell lung cancer (SCLC) accounts for about 20% of total lung cancer, and systemic chemotherapy is the major therapy for all stages of SCLC. Although most SCLC patients are characterized by initial chemosensitivi... ...